Skip to main content

Advertisement

SpringerLink
Log in

Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objectives

Across diagnosis groups, transition of adolescents and young adults from children’s hospitals to adult care associates with decreased treatment adherence and suboptimal treatment results. Our aim was to compare the health-related quality of life (HRQoL) and disease activity of juvenile idiopathic arthritis (JIA) patients after the transfer of care to the adult clinic and adult patients in the same outpatient clinic.

Methods

All consecutive JIA patients aged 16 to 20 years who visited the transition clinic between September 2016 and August 2017 and all consecutive adult onset arthritis patients between December 2016 and August 2017 in the rheumatology outpatient clinic of Helsinki University Hospital were evaluated. HRQoL was measured by a generic instrument, 15D.

Results

A total of 291 patients, 130 JIA, and 161 adults were identified with respective median disease durations of 6.5 and 4.0 years. Adults had lower HRQoL measured by 15D (median 0.90 vs. 0.96, P < 0.001) and higher Disease Activity Score 28 (DAS28) than JIA patients (median 2.4 vs. 1.6, P < 0.001). Adults smoked more frequently than JIA patients (22% vs. 7%, P < 0.001). In multiple regression, female gender, smoking, disease activity, and obesity were associated with poorer HRQoL. Smoking adults had more active disease (DAS28 median 3.1 vs. 2.1, P = 0.031) and lower HRQoL (15D median 0.86 vs. 0.93, P < 0.001) than non-smoking adults.

Conclusions

Transition phase JIA patients had acceptable HRQoL and lower disease activity than patients with adult onset rheumatic diseases with similar disease duration. Smoking was associated with more active disease and lower HRQoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767–778

    Article  PubMed  CAS  Google Scholar 

  2. Berntson L, Andersson Gare B, Fasth A et al (2003) Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 30:2275–2282

    PubMed  Google Scholar 

  3. Hersh A, von Scheven E, Yelin E, Medscape (2011) Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol 7:290–295

  4. Coulson EJ, Hanson HJ, Foster HE (2014) What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatology (Oxford) 53:2155–2166

    Article  Google Scholar 

  5. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809–2818

    Article  PubMed  Google Scholar 

  6. Bertilsson L, Andersson-Gare B, Fasth A, Petersson IF, Forsblad-D'elia H (2013) Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol 40:715–724

    Article  PubMed  Google Scholar 

  7. Elhai M, Bazeli R, Freire V, Feydy A, Drape JL, Quartier P, Kahan A, Deslandre C, Wipff J (2013) Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood. J Rheumatol 40:520–527

    Article  PubMed  Google Scholar 

  8. Laas K, Roine R, Rasanen P, Sintonen H, Leirisalo-Repo M, HUS QoL Study Group (2009) Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 29:267–273

    Article  PubMed  Google Scholar 

  9. Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, Hügle B, Radon K (2016) Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS One 11:e0153267

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767–775

    Article  PubMed  Google Scholar 

  11. Tollisen A, Selvaag AM, Aulie HA et al (2017) Physical functioning, pain and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year follow-up study. Arthritis Care Res (Hoboken)

  12. Wipff J, Sparsa L, Lohse A, Quartier P, Kahan A, Deslandre CJ (2016) Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies. Joint Bone Spine 83:69–74

    Article  PubMed  Google Scholar 

  13. Stoll ML, Cron RQ (2014) Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J 12:13. https://doi.org/10.1186/1546-0096-12-13 eCollection 2014

    Article  PubMed  PubMed Central  Google Scholar 

  14. Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM, Society for Adolescent Medicine (2003) Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health 33:309–311

    Article  PubMed  Google Scholar 

  15. Tucker LB, Cabral DA (2007) Transition of the adolescent patient with rheumatic disease: issues to consider. Rheum Dis Clin N Am 33:661–672

    Article  Google Scholar 

  16. Hazel E, Zhang X, Duffy CM, Campillo S (2010) High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 8:2. https://doi.org/10.1186/1546-0096-8-2

    Article  PubMed  PubMed Central  Google Scholar 

  17. Stringer E, Scott R, Mosher D, MacNeill I, Huber AM, Ramsey S, Lang B (2015) Evaluation of a rheumatology transition clinic. Pediatr Rheumatol Online J 13:22. https://doi.org/10.1186/s12969-015-0016-x

    Article  PubMed  PubMed Central  Google Scholar 

  18. Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Dermikaya E, Ozen S, Carmona L (2017) EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis 76:639–646

    Article  PubMed  Google Scholar 

  19. Relas H, Luosujarvi R, Kosola S (2018) Outcome of transition phase patients with juvenile idiopathic arthritis. Mod Rheumatol:1–6

  20. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145

    Article  PubMed  CAS  Google Scholar 

  21. Aletaha D, Smolen JS (2006) The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin N Am 32:9–44 vii

    Article  Google Scholar 

  22. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  PubMed  CAS  Google Scholar 

  23. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291

    PubMed  CAS  Google Scholar 

  24. Huskisson EC (1974) Measurement of pain. Lancet 2:1127–1131

    Article  PubMed  CAS  Google Scholar 

  25. Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336

    Article  PubMed  CAS  Google Scholar 

  26. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646–656

    PubMed  PubMed Central  Google Scholar 

  27. Horneff G, Burgos-Vargas R (2009) Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 27:S131–S138

    PubMed  CAS  Google Scholar 

  28. Davies R, Gaynor D, Hyrich KL, Pain CE (2017) Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum 46:584–593

    Article  PubMed  CAS  Google Scholar 

  29. Li P, Zheng Y, Chen X (2017) Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol 8:460

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Smoking in Finland (2018) Available at: https://thl.fi/en/web/alcohol-tobacco-and-addictions/tobacco/smoking-in-finland

  31. Liao KP, Alfredsson L, Karlson EW (2009) Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 21:279–283

    Article  PubMed  PubMed Central  Google Scholar 

  32. Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49–54

    Article  PubMed  CAS  Google Scholar 

  33. Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF, for the SWEFOT Trial Investigators Group (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 70:469–475

    Article  PubMed  Google Scholar 

  34. Saevarsdottir S, Wedren S, Seddighzadeh M et al (2011) Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum 63:26–36

    Article  PubMed  CAS  Google Scholar 

  35. Goldenberg M, Danovitch I, IsHak WW (2014) Quality of life and smoking. Am J Addict 23:540–562

    Article  PubMed  Google Scholar 

  36. Levitsky A, Brismar K, Hafstrom I et al (2017) Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial. RMD Open 3:e000458. https://doi.org/10.1136/rmdopen-2017-000458 eCollection 2017

    Article  PubMed  PubMed Central  Google Scholar 

  37. Nutrition, Physical Activity and Obesity Finland (2013) Available at: http://www.euro.who.int/__data/assets/pdf_file/0008/243296/Finland-WHO-Country-Profile.pdf

  38. Aaltonen KJ, Sokka T, Mottonen T et al (2014) A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland. Scand J Rheumatol 43:286–290

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

The authors received no specific funding for this work.

Author information

Authors and Affiliations

  1. Rheumatology, Helsinki University Hospital and University of Helsinki, PL 372, 00029, Helsinki, Finland

    Heikki Relas

  2. Pediatric Research Center, Children’s Hospital, Helsinki University Hospital and University of Helsinki, PL 435, 00029, Helsinki, Finland

    Silja Kosola

Authors
  1. Heikki Relas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silja Kosola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heikki Relas.

Ethics declarations

Retrospective data were used, and patients were not contacted for this study. Thus, ethics approval was not required for this study at our institution.

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Relas, H., Kosola, S. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease. Clin Rheumatol 38, 785–791 (2019). https://doi.org/10.1007/s10067-018-4351-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4351-4

Keywords

Search

Navigation